How big is the Immunoassay Market | Size, Demand & Opportunities 2025

Q: What is the market size of the immunoassay market?

It was valued at USD 9.2 Billion in 2024 and is projected to reach USD 13.22 Billion by 2031.

Q: What is the CAGR of the immunoassay market?

The immunoassay market is expected to grow at a CAGR of 5.60% from 2025 to 2031.

Q: What drives the immunoassay market?

Chronic disease burden, technological improvements, and increasing demand for early diagnostics.

Q: What are key applications of immunoassays?

Used for disease diagnosis, drug monitoring, therapeutic drug management, and biomarker discovery.

Q: Which region dominates the immunoassay market?

North America dominates due to advanced healthcare infrastructure and high diagnostics adoption.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6913

Publication Date: Jul 2025

How big is the Immunoassay Market?

According to 6Wresearch internal database and industry insights, the Global Immunoassay Market was valued at USD 9.2 Billion in 2024 and is expected to reach USD 13.22 Billion by 2031, growing at a compound annual growth rate of 5.60% during the forecast period (2025-2031).

The market is driven by the rising incidence of chronic and infectious diseases, technological advancements in diagnostic platforms, and growing demand for early disease detection and personalized treatment.

View Main Report

Schedule Analyst Call

Key Growth Drivers of the Immunoassay Market

Growing need for early disease diagnosis and management
High prevalence of infectious and chronic conditions
Technological advancements in immunoassay analyzers and reagents
Increased adoption of immunoassays in drug monitoring and oncology
Supportive healthcare policies and growing investment in diagnostics

Immunoassay Market Trends

The immunoassay market is experiencing consistent innovation with an emphasis on automation and multiplexing to improve diagnostic speed and accuracy. Point-of-care (POC) immunoassays are gaining traction due to their convenience and rapid results. The integration of AI and digital platforms is enhancing data analysis and interpretation. In addition, demand is increasing for immunoassays in home diagnostics and telehealth-based testing systems.

Emerging Developments in the Immunoassay Market

The immunoassay market is also seeing improvements of the chemiluminescence immunoassay system and the microfluidic platforms that aim at being more sensitive and decreasing the size of the sample volume. Biotech corporations are creating new biomarkers in infectious diseases and cancer. Smart device innovation in diagnostics is being backed by smart alliances between diagnostic companies and technology firms. The growth of automatization in the lab instruments as well as decentralized testing models is also being invested into, especially in emerging economies.